Handbook of drug monitoring methods : therapeutics and drugs of abuse
著者
書誌事項
Handbook of drug monitoring methods : therapeutics and drugs of abuse
Humana , Springer [distributor], c2008
- : hardcover
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
内容説明・目次
内容説明
Written in a handbook style with specific methods and tips on eliminating false positive and false negative results, this book is a practical guide to the detailed mechanisms of such occurrences.
目次
Content
1. Chapter 1: Introduction to Therapeutic Drug Monitoring. Amitava Dasgupta, Ph.D. Department of Pathology and Laboratory Medicine, University of Texas-Houston, Medical School, Houston, TX
2. Chapter 2. Monitoring Free Drug Concentration. Amitava Dasgupta, Ph.D. Department of Pathology and Laboratory Medicine, University of Texas-Houston Medical School, Houston, TX.
3. Chapter 3. Analytical Techniques for Measuring Concentrations of Therapeutic Drugs in Biological Fluids. Amitava Dasgupta and Pradip Datta. Department of Pathology and Laboratory Medicine, University of Texas-Houston Medical School, Houston, Texas and Bayer HealthCare, Diagnostics Division, Tarrytown, NY
4. Chapter 4. The Pre-Analytical Phase of Drug Testing: From Specimen Collection to Analysis. Catherine A. Hammett-Stabler, Ph.D. Department of Pathology and Laboratory Medicine University of North Carolina at Chapel Hill
5. Chapter 5. Effect of Hemolysis, High Bilirubin, Lipemia, Paraproteins and System Factors on Therapeutic Drug Monitoring. Pradip Datta, PhD. Bayer HealthCare, Diagnostics Division, Tarrytown, NY
6. Chapter 6: Digoxin: So Many Interferences and How to Eliminate Them. Amitava Dasgupta, Ph.D. Department of Pathology and Laboratory Medicine, University of Texas-Houston Medical School, Houston, TX
7. Chapter 7. Interferences with Measurement of Anticonvulsants. William Clarke, Ph.D. Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland
8. Chapter 8. Pitfalls in Measuring Antidepressant Drugs. Uttam Garg, Ph.D. Department of Pathology and Laboratory Medicine University of Missouri, Kansas City and Children's Mercy Hospitals and Clinics, Kansas City, MO.
9. Chapter 9. Immunosuppressive Drugs: Pharmacokinetics, Preanalytic Variables, and Analytical Considerations. Anthony W. Butch, Ph.D. Department of Pathology and Laboratory Medicine, Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095-1732
10. Chapter 10. Therapeutic Drug Monitoring in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. Steven J Soldin PhD. Department of Pharmacology, Georgetown University and Department of Laboratory Medicine, Children's National Medical Center
11. Chapter 11. Pharmacogenomics and Personalized Medicine: Issues and Methodology. Steven H. Y. Wong. Department of Pathology, Medical College of Wisconsin And Toxicology Department, Milwaukee County Medical Examiner's Office, Milwaukee, WI,
12. Chapter 12. Interference of Heterophilic and Other Antibodies in Measurement of Therapeutic Drugs by Immunoassays. Pradip Datta, PhD. Bayer HealthCare, Diagnostics Division, Tarrytown, NY
13. Chapter 13. Drug-Herb and Drug-Food Interactions: Impact on Therapeutic Drug Monitoring. Amitava Dasgupta, Ph.D Department of Pathology and Laboratory Medicine, University of Texas-Houston Medical School, Houston, TX
14. Chapter 14. Toxic Element Testing with Clinical Specimens. Gwendolyn A. McMillin, Ph.D.1,2 and Joshua A. Bornhorst, Ph.D. 3 1 ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, 2 Department of Pathology, University of Utah, Salt Lake City, Utah 84132, 3 Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR
15. Chapter 15. Alcohol Testing. Steve C. Kazmierczak, Ph.D and Hassan ME Azzazy, Ph.D. Department of Pathology, Oregon Health & Science University, Portland, Oregon and Department of Chemistry, The American University of Cairo, Egypt
16. Chapter 16. Introduction to Drugs of Abuse Testing. Tai C. Kwong, Ph.D. Department of Pathology, University of Rochester Medical Center, Rochester, NY
17. Chapter 17. Urinary
「Nielsen BookData」 より